Articles related to PERSONALIZED MEDICINE

A network meta-analysis of 24 antipsychotics across 78,193 patients with schizophrenia identified clozapine, amisulpride, olanzapine, and risperidone as most effective, with small-to-medium efficacy differences and notable variation in tolerability profiles.

As GLP‑1 medications become widely used for obesity and metabolic disease, clinicians are confronting a growing question: What should be done when patients don’t respond as expected?

Early cancer detection through AI-analyzed blood tests could lead to personalized mRNA vaccine production in just 48 hours, according to Oracle CEO Larry Ellison.

N=1 science empowers patients to become “citizen scientists,” experimenting and refining their health choices to find what works best for their own bodies.

A meta-analysis of 99 randomized controlled trials suggests that vitamin D supplementation may offer significant cardiometabolic benefits, with the greatest improvements seen in specific population subgroups.

Chemotherapy-free regimens for Ph+ ALL have shown complete response rates of 94-100% with minimal toxicity, potentially eliminating the need for stem cell transplant in many patients.